Interleukin 6 and its receptor: Ten years later

International Reviews of Immunology

Volumn 16, Issue 3-4, 1998, Pages 249-284

  Hirano, Toshio ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Cytokine; Interleukin 6; JAK; Receptor; Signal transduction; STAT

Indexed keywords

EID: 0031913593     PISSN: 08830185     EISSN: None     Source Type: Journal    
DOI: 10.3109/08830189809042997     Document Type: Article

References (213)

1. Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsud, T., Kashiwamura, S., Nakajima, K., Koyama, K., Iwamatsu, A., Tsunasawa, S., Sakiyama, F., Matsui, H., Takahara, Y., Taniguchi, T., and Kishimoto, T. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324, 73-76, 1986.
2. Zilberstein, A., Ruggieri, R., Korn, J. H., and Revel, M. Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines. EMBO J. 5, 2529-2537, 1986.
3. 2 interferon involved. Proc. Natl. Acad. Sci. USA 83, 8957-8961, 1986.
4. Haegeman, G., Content, J., Volckaert, G., Derynck, R., Tavernier, J., and Fiers, W. Structural analysis of the sequence encoding for an inducible 26-kDa protein in human fibroblasts. Eur. J. Biochem. 159, 625-632, 1986.
5. Muraguchi, A., Kishimoto, T., Miki, Y., Kuritani, T., Kaieda, T., Yoshizaki, K., and Yamamura, Y. T cell-replacing factor (TRF)-induced IgG secretion in human B blastoid cell line and demonstration of acceptors for TRF. J. Immunol. 127, 412-416, 1981.
6. Teranishi, T., Hirano, T., Arima, N., and Onoue, K. Human helper T cell factor(s) (ThF). II. Induction of IgG production in B lymphoblastoid cell lines and identification of T cell replacing factor (TRF)-like factor(s). J. Immunol. 128, 1903-1908, 1982.
7. Okada, M., Sakaguchi, N., Yoshimura, N., Hara, H., Shimizu, K., Yoshida, N., Yoshizaki, K., Kishimoto, S., Yamamura, Y., and Kishimoto, T. B cell growth factor (BCGF) and B cell differentiation factor from human T hybridomas: Two distinct kinds of BCGFs and their synergism in B cell proliferation. J. Exp. Med. 157, 583-590, 1983.
8. Hirano, T., Teranishi, T., and Onoue, K. Human helper T cell factor(s) III. Characterization of B cell differentiation factor I (BCDF I). J. Immunol. 132, 229-234, 1984.
9. Hirano, T., Teranishi, T., Lin, B. H., and Onoue, K. Human helper T cell factor(s) IV. Demonstration of a human late-acting B cell differentiation factor acting on Staphylococcus aureus Cowan I-stimulated B cells. J. Immunol. 133, 798-802, 1984.
10. Hirano, T., Taga, T., Nakano, N., Yasukawa, K., Kashiwamura, S., Shimizu, K., Nakajima, K., Pyun, K. H., and Kishimoto, T Purification to homogeneity and characterization of human B cell differentiation factor (BCDF or BSFp-2). Proc. Natl. Acad. Sci. USA 82, 5490-5494, 1985.
11. Sehgal, P. B., May, T. T., Tamm, I., and Vilcek, J. Human β2 interferon and B-cell differentiation factor BSF-2 are identical. Science 235, 731-732, 1987.
12. Hirano, T. and Kishimoto, T. Interleukin 6. In: Handbook of Experimental Pharmacology. Vol. 95/I, Peptide growth factors and their receptors I 1990, edited by Sporn, M. B. and Roberts, A. B. Berlin: Springer-Verlag, pp. 633-665.
13. Van Damme, J., Opdenakker, G., Simpson, R. J., Rubira, M. R., Cayphas, S., Vink, A., Billiau, A., and Snick, J. V. Identification of the human 26-kDa protein, interferon β2 (IFNβ2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor. J. Exp. Med. 165, 914-919, 1987.
14. Van Snick, J., Cayphas, S., Szikora, J. P., Renauld, J. C., Van Roost, E., Boon, T., and Simpson, R. J. cDNA cloning of murine interleukin-HP1: homology with human interleukin 6. Eur. J. Immunol. 18, 193-197, 1988.
15. Aarden, L., Lansdorp, P., and De Groot, E. A growth factor for B cell hybridomas produced by human monocytes. Lymphokines 10, 175-185, 1985.
16. Nordan, R. P. and Potter, M. A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro. Science 233, 566-569, 1986.
17. Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., Kuramoto, A., and Kishimoto, T. Autocrine generation and essential requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332, 83-85, 1988.
18. 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc. Natl. Acad. Sci. USA 84, 7251-7255, 1987.
19. Andus, T., Geiger, T., Hirano, T., Northoff, H., Ganter, U., Bauer, J., Kishimoto, T., and Heinrich, P. C. Recombinant human B cell stimulatory factor 2 (BSF-2/IFNβ2) regulates β-fibrinogen and albumin mRNA levels in Fao-9 cells. FEBS Lett. 221, 18-22, 1987.
20. Sehgal, P. B., Grienger, G , and Tosato, G. (editors) Regulation of the acute phase and immune responses: Interleukin-6. Ann. New York Acad. Sci. 557, 1-583, 1989.
21. Van Snick, J. Interleukin-6: An overreview. Annu. Rev. Immunol. 8, 253-278, 1990.
22. Heinrich, P. C., Castell, J. V., and Andus, T. Interleukin-6 and the acute phase response. Biochem. J. 265, 621-636, 1990.
23. Hirano, T. The biology of interleukin 6. Chemical Immunol. 51, 153-180, 1992.
24. Hirano, T. Interleukin 6. In: The Cytokine Handbook, 2nd edition 1994, edited by Thomson, A. W. London: Academic Press, pp. 145-168, 1994.
25. Bazan, J. F. Haemopoietic receptors and helical cytokines. Immunol. Today 11, 350-354, 1990.
26. Bazan, J. F. Neurotropic cytokines in the hematopoietic fold. Neuron 7, 1-12, 1992.
27. Bazan, J. F. A novel family of growth factor receptors: A common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-6 receptor-chain. Biochem. Biophys. Res. Comm. 164, 788-795, 1989.
28. Bazan, J. F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA 87, 6934-6938, 1990.
29. Miyajima, A., Kitamura, T., Harada, N., Yokota, T., and Arai, K. Cytokine receptors and signal transduction. Annu. Rev. Immunol. 10, 295-339, 1992.
30. Sugamura, K., Asao, H., Kondo, M., Tanaka, N., Ishii, N., Nakamura, M., and Takeshita, T. The common gamma-chain for multiple cytokine receptors. Adv. Immunol. 59, 225-277, 1995.
31. Taniguchi, T. Cytokine signaling through nonreceptor protein tyrosine kinase. Science 268, 251-255, 1995.
32. Kishimoto, T., Akira, S., Narazaki, M., and Taga, T. Interleukin-6 family of cytokines and gp130. Blood 86, 1243-1254, 1995.
33. Hibi, M., Nakajima, K., and Hirano, T. IL-6 cytokine family and signal transduction: a model of the cytokine system. J. Mol. Med. 74, 1-12, 1996.
34. Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T., and Kishimoto, T. Interleukin 6 (IL-6) triggers the association of its receptor (IL-6-R) with a possible signal transducer, gp130. Cell 58, 573-581, 1989.
35. Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T., and Kishimoto, T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63, 1149-1157, 1990.
36. Gearing, D. P., Comeau, M. R., Friend, D. J., Gimpel Thut, C. J., Mcgourty, J., Brasher, K. K., King, J. A., Gills, S., Mosley, B., Ziagler, S. F., and Cosman, D. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science 255, 1434-1437, 1992.
37. Ip, N. Y., Nye, S. H., Boulton, T. G., Davis, S., Taga, T., Li, Y., Birren, S. J., Yasukawa, K., Kishimoto, T., Anderson, D. J., Stahl, N., and Yancopoulos, G. D. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 69, 1121-1132, 1992.
38. Yin, T., Taga, T., Tsang, M. L.-S, Yasukawa, K., Kishimoto, T., and Yang, Y.-C. Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction. J. Immunol. 151, 2555-2561, 1993.
39. Taga, T., Narazaki, M., Yasukawa, K., Saito, T., Miki, D., Hamaguchi, M., Davis, S., Shoyab, M., Yancopoulos, G. D., and Kishimoto, T. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130. Proc. Natl. Acad. Sci. USA 89, 10998-11001, 1992.
40. Pennica, D., King, K. L., Shaw, K. L., Luis, E., Rullamas, J., Luoh, S., Darbonne, W. C., Knutzon, D. S., Yen, R., Chien, K. R., Baker, J. B., and Wood, W. I. Expression cloning of cardiotrophin-1, a cytokine that induces cardiac myocyte hypertrophy. Proc. Natl. Acad. Sci. USA 92, 1142-1146, 1995.
41. Ihle, J. N., Witthuhn, B. A., Quelle, F. W., Yamamoto, K., Thierfelder, W. E., Kreider, B., and Silvennovinen, O. Signaling by the cytokine receptor superfamily, JAKs and STATs. TIBS 19, 222-227, 1994.
42. Darnell, J. E., Kerr, I. M., and Stark, G. M. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 257, 803-806, 1994.
43. Schindler, C. and Darnell, J. E. Jr. Transcriptional responses to polypeptide ligands: The JAK-STAT pathway. Annu. Rev. Biochem. 64, 621-651, 1995.
44. Ihle, J. N. STATs: Signal transducers and Activators of Transcription. Cell 84, 331-334, 1996.
45. Suematsu, S., Matsuda, T., Aozasa, K., Akira, S., Nakano, N., Ohno, S., Miyazaki, J., Yamamura, K., Hirano, T., and Kishimoto, T. IgG1 plasmacytosis in interleukin 6 transgenic mice. Proc. Natl. Acad. Sci. USA 86, 7547-7551, 1989.
46. Brandt, S. J., Bodine, D. M., Dunbar, C. E., and Nienhuis, A. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. J. Clin. Invest. 86, 592-599, 1990.
47. Suematsu, S., Matsusaka, T., Matsuda, T., Ohno, S., Miyazaki, J., Yamamura, K., Hirano, T., and Kishimoto, T. Generation of transplantable plasmacytomas with t(12;15) in Il-6 transgenic mice. Proc. Natl. Acad. Sci. USA 89, 232-235, 1992.
48. Hirano, T. Interleukin 6 (IL-6) and its receptor: Their role in plasma cell neoplasias. Int. J. Cell Cloning 9, 166-184, 1991.
49. Hilbert, D. M., Kopf, M., Mock, B. A., Kohler, G., and Rudikoff, S. Interleukin 6 is essential for in vivo development of B lineage neoplasms. J. Exp. Med. 182, 243-248, 1995.
50. Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., and Kohler, G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368, 339 342, 1994.
51. Beagley, K. W., Eldridge, J. H., Lee, F., Kiyono, H., Everson, M. P., Koopman, W. J., Hirano, T., Kishimoto, T., and McGhee, J. R. Interleukins and IgA synthesis: Human and murine IL-6 induce high rate IgA secretion in IgA-committed B cells. J. Exp. Med. 169, 2133-2148, 1989.
52. Fujihashi, K., McGhee, J. R., Lue, C., Beagley, K. W., Taga, T., Hirano, T., Kishimoto, T., Mestecky, J., and Kiyono, H. Human appendix B cells naturally express receptors for and respond to interleukin 6 with selective IgA1 and IgA2 synthesis. J. Clin. Invest 88, 248-52, 1991.
53. Ramsay, A. J., Husband, A. J., Ramshaw, I. A., Bao, S., Matthaei, K. I., Koehler, G., and Kopf, M. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264, 561-563, 1994.
54. Dalrymple, S. A., Lucian, L. A., Slattery, R., McNeil, T., Aud, D. M., Fuchino, S., Lee, F., and Murray, R. Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutorphilia. Infect. Immun. 63, 2262-2268, 1995.
55. Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., and Manolagas, S. C. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257, 88-91, 1992.
56. Girasole, G., Jilka, R. L., Passeri, G., Boswell, S., Boder, G., Williams, D. C. and Manolagas, S. C. 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J. Clin. Invest. 89, 883-891, 1992.
57. Poli, V., Balena, R., Fattori, E., Markatos, A., Yamamoto, M., Tanaka, H., Ciliberto, G., Rodan, G. A., and Costantini, F. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion EMBO J. 13, 1189-1196, 1994.
58. Chai, Z., Gatti, S., Toniatti, C., Poli, V., and Barfai, T. Interleukin(IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice. J. Exp. Med. 183, 311-316, 1996.
59. Gearing, D., Gough, N. M., King, J. A., Hilto, D. J., Nicola, N. A., Simpson, R. J., Nice, E. C., Kelso, A., and Metcalf, D. Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF). EMBO J. 6, 3995-4002, 1987.
60. Hilton, D. J. LIF. lots of interesting functions. Trends Biochem. Sci. 17, 72-76, 1992.
61. Williams, R. L., Hilton, D. J., Pease, S., Wilson, T. A., Stewart, C. L., Gearing, D. P., Wagner, E. F., Metcalf, D., Nicola, N. A., Gough, N. M. Myeloid leukemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336, 684-687, 1988.
62. Mori, M., Yamaguchi, K., and Abe, K. Purification of a lipoprotein lipase-inhibiting protein produced by a melanoma cell line associated with cancer cachexia. Biochem. Biophys. Res. Commun. 160, 1085-1092, 1989.
63. Yamamori, T., Kukada, K., Abersold, R., Korsching, S., Fann, M J., and Patterson, P. H. The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor. Science 246, 1412-1416, 1989.
64. Lin, L.-F. H., Mismer, D., Lile, J. D., Armes, L. G., Butler, E. T. III, Vannice, J. L., and Collins, F. Purification, cloning, and expression of ciliary neurotrophic factor (CNTF). Science 246, 1023-1025, 1989.
65. Adler, R., Landa, K., Manthorpe, M., and Varon, S. Cholinergic neurotrophic factors: Intraocular distribution of trophic activity for ciliary neurons. Science 204, 1434-1436, 1979.
66. Barbin, G., Manthorpe, M., and Varon, S. Purification of chick eye ciliary neurotrophic factor. J. Neurochem. 43, 1468-1478, 1984.
67. Manthorpe, M., Skaper, S., Williams, L. R., and Varon, S. Purification of adult rat sciatic nerve ciliary neurotrophic factor. Brain. Res. 367, 282-286, 1986.
68. Ernsberger, U., Sendtner, M., and Rohrer, H. Proliferation and differentiation of embryonic chick symphathetic neurons: effects of ciliary neurotrophic factor. Neuron, 1275-1284, 1989
69. Saadat, S., Sendtner, M., and Rohrer, H. Ciliary neurotrophic factor induces cholinergic differentiation of rat sympathetic neurons in culture. J. Cell. Biol. 108, 1807-1816, 1989.
70. Hughes, S. M., Lillien, L. E., Raff, M. C., Rohrer, H., and Sedtner, M. Ciliary neurotrophic factor induces type-2 astrocyte differentiation in culture. Nature 335, 70-73, 1988.
71. Sendtner, M., Kreutzberg, G. W., and Thoenen, H. Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 345, 440-441, 1990.
72. Murphy, M., Reid, K., Hilton, D. J., and Bartlett, P. F. Generation of sensory neurons is stimulated by leukemia inhibitory factor. Proc. Natl. Acad. Sci. USA 88, 3498-3501, 1991.
73. Malik, N., Kalestad, J. C., Gunderson, N. L., Austin, S. D., Neubauer, M. G., Ochs, V., Marquardt, H., Zarling, J. M., Shoyab, M., Wei, C.-M., Linsley, P., and Rose, T. M. Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M. Mol. Cell. Biol. 9, 2847-2853, 1989.
74. Zarling, J. M., Shoyab, M., Marquardt, H., Hanson, M. B., Lioubin, M N , and Todaro, G. J. Oncostatin M. A growth regulator produced by differentiated histiocytic lymphoma cells. Proc. Natl. Acad. Sci. USA 83, 9739-9743, 1986.
75. Nair, B. C., DeVico, A. L., Nakamura, S., Copeland, T. D., Chen, Y., Patel, A., O'Neil, T., Oroszlan, S., Gallo, R. C., and Sarngadharan, M. G. Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science 255, 1430-1432, 1992.
76. Miles, S. A., Martinez-Maza, O., Rezai, A., Magpantay, L., Kishimoto, T., Nakamura, S., Radka, S. F., and Linsley, P. S. Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science 255, 1432-1434, 1992.
77. Paul, S. R., Bennett, F., Calvetti, J. A., Kelleher, K., Wood, C. R., O'Hara, R. M., Jr., Leary, A. C., Sibley, B., Clark, S. C., Williams, D. A., and Yang, Y.-C. Proc. Natl. Acad. Sci. USA 87, 7512-7516, 1990.
78. Yin, T., Schendel, P., and Yang, Y. C. Enhancement of in vivo and in vitro antigen-specific antibody responses by interleukin-11. J. Exp. Med. 175, 211-216, 1992.
79. Pennica, D., Shaw, T. A., Swanson, M. W., Moore, D. L., Sjelton, K. A., Zioncheck, A , Rosenthal, A., Taga, T., Paoni, N. F., and Wood, W. I. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J. Biol Chem 270, 10915-10922, 1995.
80. Metcalf, D. Actions and interactions of G-CSF, LIF, and IL-6 on normal and leukemia murine cells. Leukemia 3, 349-355, 1989.
81. Rose, T. M. and Bruce, A. G. Oncostatin M is a member of a cytokine family which includes leukemia inhibitory factor, granulocyte colony-stimulatory factor and interleukin-6. Proc. Natl. Acad. Sci. USA 88, 8641-8645, 1991.
82. Zhang, X. G., Gu, J. J., Lu, Z. Y., Yasukawa, K., Yancopoulos, G. D., Turner, K., Shoyab, M., Taga, T., Kishimoto, T., Bataille, R., and Klein, B. Ciliary neurotrophic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130. J. Exp. Med. 179, 1337-1342, 1994.
83. Musashi, M., Yang, Y. C., Paul, S. R , Clark, S C., Sudo, T., and Ogawa, M. Direct and synergistic effects of interleukin-11 on murine hemopoiesis in culture. Proc. Natl. Acad. Sci. USA 88, 765-769, 1991
84. Leary, A. G., Zeng, H Q., Clark, S. C., and Ogawa, M. Growth factor requirements for survival in G0 and entry into the cell cycle of primitive human hemopoietic progenitors. Proc. Natl. Acad. Sci. USA 89, 4013-4017, 1992.
85. Baumann, H., Onorato, V., Gauldie, J., and Jahreis, G. P. Distinct sets of acute phase plasma proteins are stimulated by separate human hepatocyte-stimulating factors and monokines in rat hepatoma cells. J. Biol. Chem. 262, 9756-9768, 1987.
86. Baumann, H. and Wong, G. G. Hepatocyte-stimulatory factor III shares structural and functional identity with leukemia inhibitory factor. J. Immunol. 143, 1163-1167, 1989.
87. Richards, C. D., Brown, T. J., Shoyab, M., Baumann, H., and Gauldie, J. Recombinant oncostatin M stimulates the production of acute phase protein in HepG2 cells and rat primary hepatocytes in vitro. J. Immunol. 148, 1731-1736, 1992.
88. Baumann, H. and Schendel, P. Interleukin 11 regulates the hepatic expression of the same plasma protein genes as interleukin-6. J. Biol. Chem. 266, 20424-20427, 1991.
89. Patterson, P. H. and Nawa, H. Neuronal differentiation factors/cytokines and synaptic plasticity. Cell 72, 123-137, 1993.
90. Yamasaki, K., Taga, T., Hirata, Y., Yawata, H., Kawanishi, Y., Seed, B., Taniguchi, T., Hirano, T., and Kashimoto, T. Cloning and expression of the human interleukin-6 (BSF-2/IFNb2) receptor. Science 241, 825-828, 1988.
91. Sugita, T., Totsuka, T., Saito, M., Yamasaki, K., Taga, T., Hirano, T., and Kishimoto, T. Functional murine IL-6 receptor with the intracisternal A-particle gene product at its cytoplasmic domain: Its possible role in plasmacytomagenesis. J. Exp. Med. 171, 2001-2009, 1990.
92. Paonessa, G., Graziani, R., Serio, A. D., Svio, R., Ciappori, L., Lahm, A., Salvati, A. L., Tniatti, C., and Ciliberto, G. Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling. EMBO J. 14, 1942-1951, 1995.
93. Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., Loudon, R., Sherman, F., Perrussia, B., and Trinchieri, G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170, 827-845, 1989.
94. Gearing, D. P. and Cosman, D. Homology of the p40 subunit of natural killer cell stimulatory factor (NKSF) with the extracellular domain of the interleukin-6 receptor. Cell 66, 9-10, 1991.
95. Chua, A. O., Chizzonite, R., Desai, B. B., Truitt, T. P., Nunes, P., Minetti, L. J., Warrier, R. R., Presky, D. H., Levine, J. F., Gately, M. K., and Gubler, U. Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp120. J. Immunol. 153, 128-136, 1994.
96. Davis, S., Aldrich, T. H., Ip, N. Y., Stahl, N., Scherer, S., Farruggella, T., DiStefano, P. S., Curtis, R., Panayotatos, N., Gascan, H., Chevalier, S., and Yancopoulos, G. D. Released form of CNTF receptor a components as a soluble mediator of CNTF responses. Science 259, 1736-1739, 1993.
97. Hirota, H., Yoshida, K., Kishimoto, T., and Taga, T. Continuous activation of gp130, a signal transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc. Natl. Acad. Sci. USA 92, 4862-4866, 1995.
98. Treanor, J. J. S., Goodman, L., de Sauvage, F., Stone, D. M., Poulsen, K. T., Beck, C. D., Gray, C., Armanini, M. P., Pollock, R. A., Hefti, F., Phillips, H. S., Goddard, A., Moore, M. W., Buj-Bello, A., Davies, A. M., Asai, N., Takahashi, M., Vandlen, R., Henderson, C. E., and Rosenthal, A. Characterization of a multi-component receptor for GDNF. Nature 382, 80-83, 1996.
99. Jing, S., Wen, D., Yu, Y., Holst, P. L., Luo, Y., Fang, M., Tamir, R., Antonio, L., Hu, Z., Cupples, R., Louis, J.-C., Hu, S., Altrock, W. B., and Fox, G. M. GDNF-Induced Activation of the ret protein tyrosine kinase is mediated by GDNFR - a novel receptor for GDNF. Cell 85, 1113-1124, 1996.
100. Velazquez, L., Fellous, M., Stark, G. R., and Pellegrini, S. A protein tyrosine kinase in the interferon a/b signaling pathway. Cell 70, 313-322, 1992.
101. Witthuhn, B. A., Quelle, F. W., Silvennoinen, O., Yi, T., Tang, B., Miura, O., and Ihle, J. N. Jak2, associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74, 227-236, 1993.
102. Argetsinger, L. S., Campbell, G. S., Yang, X., Witthuhn, B. A., Silvennoinen, O., Ihle, J. N., and Carter, -Su. C. Identification of Jak2 as a growth hormone receptor-associated tyrosine kinase. Cell 74, 237-244, 1993.
103. Lutticken, C., Wegenka, U. M., Yuan, J., Buschmann, J., Schindler, C., Ziemiecki, A., Harpur, A. G., Wilks, A. F., Yasukawa, K., Taga, T., Kishimoto, T., Barbieri, G., Pellegrini, S., Sendtner, M., Heinrich, P. C., and Horn, F. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science 263, 89-92, 1993.
104. Stahl, N., Boulton, T. G., Farruggella, T., Ip, N. Y., Davis, S., Witthuhn, B. A., Quelle, F. W., Silvernnoinen, O., Barbieri, G., Pellgrini, S., Ihle, J. N., and Yancopoulos, G. D. Association and activation of Jak/Tyk kinases by CNTF/ LIF/OSM/IL-6 b receptor components. Science 263, 92-95, 1993.
105. Matsuda, T., Yamanaka, Y., and Hirano, T. Interleukin-6-induced tyrosine phosphorylation of multiple proteins in murine hematopoietic lineage cells. Biochem. Biophys. Res. Comm. 200, 821-828, 1994.
106. Akira, S., Nishio, Y., Inoue, M., Wang, X. J., Wei, S., Matsusaka, T., Yoshida, K., Sudo, T., Naruto, M., and Kishimoto, T. Molecular cloning of APRF, a novel IFN-stimulated gene factor3 p91-related transcriptional factor involved in the gp130-mediated signaling pathway. Cell 77, 63-71, 1994.
107. Zhong, Z., Wen, Z., and Darnell, J. E. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6 Science 264, 95-98, 1994.
108. Fujitani, Y., Nakajima, K., Kojima, H., Nakae, K., Takeda, T., and Hirano, T. Transcriptional activation of the IL-6 responsive element in the junB promoter is mediated by multiple Stat family proteins. Biochem. Biophys. Res. Commun. 202, 1181-1187, 1994.
109. Nakajima, K., Matsuda, T., Fujitani, Y., Kojima, H., Yamanaka, Y., Nakae, K., Takeda, T., and Hirano, T. Signal transduction through IL-6 receptor: Involvement of multiple protein kinases, Stat factors, and a novel H7-sensitive pathway. Annal of New York Academy of Science 762, 55-70, 1995.
110. Lai, C. F., Ripperger, J., Morella, K. K., Wang, Y., Gearing, D. P., Horseman, N. D., Campos, S. P., Fey, G. H., and Baumann, H. STAT3 and STAT5B are targets of two different signal pathways activated by hematopoietin receptors and control transcription via separate cytokine response elements. J. Biol. Chem. 270, 23254-23257, 1995.
111. Fujitani, Y., Hibi, M., Fukada, T., Takahashi-Tezuka, M., Yoshida, H., Yamaguchi, T., Sugiyama, K., Yamanaka, Y., Nakajima, K., and Hirano, T. An alternative pathway for STAT activation that is mediated by the direct interac-tion between JAK and STAT. Oncogene 14, 751-761, 1997.
112. Akira, S., Isshiki, H., Sugita, T., Tanabe, O., Kinoshita, S., Nishio, Y., Nakajima, T., Hirano, T., and Kishimoto, T. A nuclear factor for IL-6 expression (NF-IL-6) is a member of a C/EBP family. EMBO J. 9, 1897-1906, 1990.
113. Baumann, H., Morella, K. K., Campos, S. P., Cao, Z., and Jahreis, G. P. Role of CAAT-enhancer binding protein isoforms in the cytokine regulation of acute-phase plasma protein genes. J. Biol. Chem. 267, 19744-19751, 1992.
114. Baumann, H., Ziegler, S. F., Mosley, B., Morella, K. K., Pajovie, S., and Gearing, D. P. Reconstitution of the response to leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in hepatoma cells. J. Biol. Chem. 268, 8414-8417, 1993.
115. Wegenka, U. M., Buschmann, J., Lutticken, C., Heinrich, P. C., and Horn, F. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol. Cell. Biol 13, 276-288, 1993.
116. Nakajima, K., Kusafuka, T., Takeda, T., Fujitani, Y., Nakae, K., and Hirano, T. Identification of a novel interleukin 6 responsive element containing an Ets-binding site and a CRE-like site in the junB promoter. Mol. Cell. Biol. 13, 3027-3041, 1993.
117. Kojima, H., Nakajima, K., and Hirano, T. IL-6-induced complexes on an IL-6 response element of the junB promoter contain Stat3 and 36kDa CRE-like site binding protein(s) Oncogene 12, 547-554, 1996.
118. Zhang, X., Blenis, J., Li, H. C., Schindler, C., and Chen-Kiang, S. Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 267, 1990-1994, 1995.
119. Wen, Z., Zhong, Z., and Darnell, J. E. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82, 241-250, 1995.
120. Fukunaga, R., Ishizaka-Ikeda, E., Pan, C. X., Seto, Y., and Nagata, S. Functional domains of the granulocyte colony-stimulating factor receptor. EMBO J. 10, 2855-2865, 1991.
121. Murakami, M., Narazaki, M , Hibi, M., Yawata, H., Yasukawa, K., Hamaguchi, M., Taga, T., and Kishimoto, T. Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc. Natl. Acad. Sci. USA 88, 11349-11353, 1991.
122. Narazaki, M., Witthuhn, B. A., Yoshida, K., Silvennoinen, O., Yasukawa, K., Ihle, J. N., Kishimoto, T., and Taga, T. Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130. Proc. NatL Acad. Sci. 91, 2285-2289, 1994.
123. Stahl, N., Farruggella, T. J., Boulton, T. G., Zhong, Z., Darnell, J. J., and Yancopoulos, G. D. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267, 1349-1353, 1995.
124. Yamanaka, Y., Nakajima, K., Fukada, T., Hibi, M., and Hirano, T. Differentiation and growth arrest signals generate through the cytoplasmic region of gp130 that is essential for Stat3 activation. EMBO J. 15, 1557-1565, 1996.
125. Baumann, H., Symes, A. J., Comeau, M. R., Morella, K. K., Wang, Y., Friend, D., Ziegler, S. F., Fink, J. S., and Gearing, D. P. Multiple regions within the cytoplasmic domains of the leukemia inhibitory factor receptor and gp130 cooperate in signal transduction in hepatic and neuronal cells. Mol. Cell. Biol. 14, 138-146, 1994.
126. Shabo, Y., Lotem, J., Rubinstein, M., Revel, M., Clark, S. C., Wolf, S. F., Kamen, R., and Sachs, L. The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin 6. Blood 72, 2070-2073, 1988.
127. Miyaura, C., Onozaki, K., Akiyama, Y., Taniyama, T., Hirano, T., Kishimoto, T., and Suda, T. Recombinant human interleukin 6 (B-cell stimulatory factor 2) is a potent inducer of differentiation of mouse myeloid leukemia cells (M1). FEBS Lett. 234, 17-21, 1988.
128. Oritani, K., Kaisho, T., Nakajima, K., and Hirano, T. Retinoic acid inhibits interleukin 6-induced macrophage differentiation and apoptosis in a murine hematopoietic cell line, Y6. Blood 80, 2298-2305, 1992.
129. Nakajima, K., Yamanaka, Y., Nakae, K., Kojima, H., Kiuchi, N., Ichiba, M., Kitaoka, T., Fukada, T., Hibi, M., and Hirano, T. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in- M1 leukemia cells. EMBO J. 15, 3651-3658, 1996.
130. Minami, M., Inoue, M., Wei, S., Takeda, K., Matsumoto, M., Kishimoto, T., and Akira, S. STAT3 activation is a critical step in gp1430-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc. Natl. Acad. Sci. USA 93, 3963-3966, 1996.
131. Fukada, T., Hibi, M., Yamanaka, Y., Takahashi-Tezuka, M., Fujitani, Y., Yamaguchi, T., Nakajima, K., and Hirano, T. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity 5, 449-460, 1996.
132. Durbin, J. E., Hackenmiller, R., Simon, M. C., and Levy, D. E. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84, 443-450, 1996.
133. Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., Carver-Moore, K., DuBois, R. N., Clark, R., Aguet, M., and Schreiber, R. D. Targeted disruption of the mouse Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84, 431-442, 1996.
134. Takeda, K., Tanaka, T., Shi, W., Matsumoto, M., Minami, M., Kashiwamura, S., Nakanishi, K., Yoshida, N., Kishimoto, T., and Akira, S. Essential role of Stat6 in IL-4 signalling. Nature 380, 627-630, 1996.
135. Shimoda, K., Deursen, J. V., Sangster, M. Y., Sarawar, S. R., Carson, R. T., Tripp, R. A., Chu, C., Quelle, F. W., Nosaka, T. D., Vignali, A. A., Doherty, P. C., Grosveld, G., Paul, W. E., and Ihle, J. N. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380, 630-633, 1996.
136. Kaplan, M. H., Schindler, U., Smiley, S. T., and Grusby, M. J. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 4, 313-319, 1996.
137. Thierfelder, W. E., van Deursen, J. M., Yamamoto, K., Tripp, R. A., Sarawar, S. R., Carson, R. T., Sangster, M. Y., Vignali, D. A. A., Doherty, P. C., Grosveld, G. C., and Ihle, J. N. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382, 171-174, 1996
138. Kaplan, M. H., Sun, Ya-Lin., Hoey, T., and Grusby, M. J. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382, 174-177, 1996.
139. Hou, X. S-, Melnick, M. B., and Perrimon, N. Marelle acts downstream of the Drosophila HOP/JAK kinase and encodes a protein similar to the mammalian STATs. Cell 84, 411-419, 1996.
140. Yan, R., Small, S., Desplan, C., Dearolf, C. R., and Darnell, J. E. Jr. Identification of a Stat gene that functions in Drosophila development. Cell 84, 421-430, 1996.
141. Greenlund, A. C., Farrar, M. A., Viviano, B. L., and Schreiber, R. D. Ligand-induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). EMBO J. 13, 1591-1600, 1994.
142. Hou, J., Schindler, U., Henzel, W. J., Ho, T. C., Brasseur, M., and McKnight, S. L. An interleukin-4-induced transcription factor: IL-4 Stat. Science 265, 1701-1706, 1994.
143. Fujii, H., Nakagawa, Y., Schindler, U., Kawahara, A., Mori, H., Gouilleux, F., Groner, B., Ihle, J. N., Minami, Y., Miyazaki, T., and Taniguchu T. Activation of StatS by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission. Proc. Natl. Acad. Sci. 92, 5482-5486, 1995
144. Friedmann, M. C., Migone, T. S., Russel, S. M., and Leonard, W. J. Different interleukin 2 receptor b-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation. Proc. Natl. Acad. Sci. 93, 2077 2082, 1996.
145. Gobert, S., Chretien, S., Gouilleux, F., Muller, O., Pallard, C., Fourt, I. D., Groner, B., Lacombe, C., Gisselbrecht, S , and Mayeux, P. Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation. EMBO J. 15, 2434-2441, 1996.
146. Frederic, W. Q., Wang, D., Nosaka, T., Thierfelder, W. E., Stravopodis, D., Weinstein, Y., and Ihle, J. N Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol. Cell. Biol. 16, 1622-1631, 1996.
147. Mui, A. L., Wakao, H., O'Farrell, A. M., Harada, N., and Miyajima, A. Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STATS homologs. EMBO J. 14, 1166-1175, 1995.
148. Yoshikawa, A., Murakami, H., and Nagata, S. Distinct signal transduction through the tyrosine-containing domains of the granulocyte colony-stimulating factor receptor. EMBO J. 14, 5288-5296, 1995.
149. Miyazaki, T., Kawahara, A., Fuji, H., Nakagawa, Y., Minami, Y., Liu, Z. J., Oishi, I., Silvennoinen, O., Witthuhn, B. A., Ihle, J. N., and Taniguchi, T. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 286, 1045-1047, 1994.
150. Muller, M., Briscoe, J., Laxton, C., Guschin, D., Ziemiecki, A., Silennoinen, O., Harpur, A. G., Barbieri, G., Witthuhn, B.A., Schindler, C., Pellegrini, S., Wilks, A. F., Ihle, J. N., Stark, G. R., and Kerr, I. M. The protein tyrosine kinase Jak1 complements defects in interferon-a/b and -g signal
151. Guschin, D., Rogers, N., Briscoe, J., Witthuhn, B. A., Wathing, D., Horn, F., Pellegrini, S., Yasukawa, K., Heinrich, P., Stark, G. R., Ihle, J. N., and Kerr, I. M. A major role for the protein kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6. EMBO J. 14, 1421-1429, 1995.
152. Kumar, G., Gupta, S., Wang, S., and Nel, A. E. Involvement of Janus kinases, p52shc, Raf-1, and MEK1 in the IL-6-induced mitogen-activated protein kinase cascade of a growth responsive B cell line. J. Immunol. 153, 4436-4447, 1994.
153. Ernst, M., Gearing, D. P., and Dunn, A. R. Functional and biochemical association of Hck with the LIF/IL-6 receptor signal transducing subunit gp130 in embryonic stem cells. EMBO J. 13, 1574-1584, 1994.
154. Matsuda, T., Takahashi-Tezuka, M., Fukada, T., Okuyama, Y., Furutani, Y., Tshukada, S., Mano, H., Hirai, H., Witte, O. N., and Hirano, T. Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines. Blood 85, 627-633, 1995.
155. Matsuda, T., Fukada, T., Takahashi-Tezuka, M., Okuyama, Y., Fujitani, Y., Hanazono, Y., Hirai, H., and Hirano, T. Activation of Fes tyrosine kinase by gp130, an interleukin-6 family cytokine signal transducer, and their association. J. Biol. Chem. 270, 11037-11039, 1995.
156. Takahashi-Tezuka, M., Hibi, M., Fujitani, Y., Fukada, T., Yamaguchi, T., and Hirano, T. Tec-type tyrosine kinase links the cytokine receptors to PI-3 kinase probably through JAK. Oncogene in press, 1997.
157. Hirano, T., Taga, T., Yasukawa, K., Nakajima, K., Nakano, N., Takatsuki, F., Shimizu, M., Murashima, A., Tsunasawa, S., Sakiyama, F., and Kishimoto, T. Human B cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production. Proc. Natl. Acad. Sci. USA 84, 228-231, 1987.
158. Hirano, T., Teranishi, T., Toba, T., Sakaguchi, N., Fukukawa, T., and Tsuyuguchi, I. Human helper T cell factor(s) (ThF). I. Partial purification and characterization. J. Immunol. 126, 517-522, 1981.
159. Shoenfeld, Y. and Isenberg, D. A. Mycobacteria and autoimmunity. Immunol. Today 9, 178-182, 1988.
160. Sela, O., E. I.-Roeiy, A., Pick, A. I., and Shoenfeld, Y. Serum immunoglobulin levels in patients with active pulmonary tuberculosis and patients with Klebsiella infection. Immunol. Lett. 15, 117-120, 1987.
161. Isobe, T. and Osserman, E. F. Pathologic conditions associated with plasma cell dyscrasias: A study of 806 cases. Annals New York Acad. Sci. 190, 507-517, 1971.
162. Isomaki, H. A., Hakulinen, T., and Joutsenlahti, U. Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J. Chron. Dis. 31, 691-696, 1978.
163. Rook, G. A. W. and Stanford, J. L. Slow bacterial infections or autoimmunity? Immunol. Today 13, 160-164, 1992.
164. Potter, M. and Boyce, C. Induction of plasma cell neoplasms in strain Balb/c mice with mineral oil and mineral oil adjuvants. Nature 193, 1086-1087, 1962.
165. Potter, M. and Wax, J. S. Genetics of susceptibility to pristane-induced plasmacytomas in BALB/cAn: reduced susceptibility in BALB/cJ with a brief description of pristane-induced arthritis. J. Immunol. 127, 1591-1595, 1981.
166. Satoh, M. and Reeves, W. H. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J. Exp. Med. 180, 2341-6, 1994.
167. Hirano, T., Matsuda, T., Turner, M., Miyasaka, N., Buchan, G., Tang, B., Sato, K., Shimizu, M., Maini, R., Feldman, M., and Kishimoto, T. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur. J. Immunol. 18, 1797-1801, 1988.
168. Houssiau, F. A., Devogel, J. P., Van Damme, J., De Deuxchaisnes, C. N., and Van Snick, J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum. 31, 784-788, 1988.
169. Bhardwaj, N., Santhanam, U., Lau, L. L., Tatter, S. B., Ghrayeb, J., Rivelis, M., Steinman, R. M., Sehgal, P. B., and May, L. T. IL-6/IFN-b2 in synovial effusions of patient with rheumatoid arthritis and other arthritides. J. Immunol. 143, 2153-2159, 1988.
170. Hermann, E., Fleischer, B., Mayer, W. J., Poralla, T., and Meyer Zum Beschernfelde, K. H. Correlation of synovial fluid interleukin 6 (IL-6) activities with IgG concentrations in patients with inflammatory joint disease and osteoarthritis. Clin. Exp. Rheumatol. 7, 411-414, 1989.
171. Guerne, P. A., Zuraw, B. L., Vaughan, J. H., Carson, D. A., and Lotz, M, Synovium as a source of interleukin 6 in vitro: contribution to local and systemic manifestations of arthritis. J. Clin. Invest. 83, 585-592, 1989.
172. Shinmei, M., Masuda, K., Kikuch, T., and Shimomura, Y. The role of cytokines in chondrocyte mediated cartilage degradation. J. Rheumatol. 16, 32-34, 1989.
173. Takai, Y., Seki, N., Senoh, H., Yokota, T., Lee, F., Hamaoka, T , and Fujiwara, H. Enhanced production of interleukin-6 in mice with type II collagen-induced arthritis. Arthritis Rheum. 32, 594-600, 1989.
174. Tang, B., Matsuda, T., Akira, S., Nagata, N., Ikehara, S., Hiranio, T., and Kishimoto, T. Age-associated increase in interleukin-6 in MRL/lpr mice. International Immunol. 3, 273-278, 1991.
175. Taga, T., Kawanishi, K., Hardy, R. R., Hirano, T., and Kishimoto, T. Receptors for B cell stimulatory factor 2 (BSF-2): Quantitation. Specificity, Distribution and Regulation of the Expression. J. Exp. Med. 166, 967-981, 1987.
176. Tanaka, Y., Saito, K., Shirakawa, F., Ota, T., Suzuki, Sumiya, H. E., and Yamashita, Y. Production of B cell-stimulating factors by B cells in patients with systemic lupus erythematosus. J. Immunol. 141, 3043-3049, 1988.
177. Klashman, D. J., Martin, R. A., Martinez-Maza, O., and Stevens, R. H. In vitro regulation of B cell differentiation by interleukin-6 and soluble CD23 in systemic lupus erythematosus B cell subpopulations and antigen-induced normal B cells. Arthritis and Rheumatism 34, 276-286, 1991.
178. Nagafuchi, H., Suzuki, N., Mizuchima, Y., and Sakane, T. Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus. J. Immunol. 151, 6525-6534, 1993.
179. + cells. Inter. Immunol. 4, 1407-1412, 1992.
180. - anti-DNA antibody-producing B cells in murine lupus. Autoimmunity 14, 205-214, 1993.
181. Ryffel, B., Car, B. D., Gunn, H., Roman, D., Hiestand, P., and Mihatsch, M. J. Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice. Am. J. Pathol. 144, 927-37, 1994.
182. Bendtzen, K., Buschard, K., Diamant, M., Horn, T., and Svenson, M. Possible role of IL-1, TNF-alpha, and IL-6 in insulin-dependent diabetes mellitus and autoimmune thyroid disease. Lymphokine Res. 8, 335-340, 1989.
183. Campbell, I. L., Cutri, A., Wilson, A., and Harrison, L. C. Evidence for IL-6 production by and effects on the pancreatic beta-cell. J. Immunol. 143, 1188-1191, 1989.
184. Campbell, I. L. and Harrison, C. A new view of the beta cell as an antigen-presenting cell and imunogenic target. J Autoimmunity 3, 53-62, 1990.
185. Rook, G. A. W., Thompson, S., Buckley, M., Elson, C., Brealey, R., Lambert, C., White, T., and Rademacher, T. The role of oil and agalactosyl IgG in the induction of arthritis in rodent models. Eur. J. Immunol. 21, 1027-1032, 1991.
186. Nakao, H., Nishikawa, A., Nishiura, T., Kanayama, Y., Tarui, S., and Taniguchi, N. Hypogalactosylation of immunoglobulin G sugar chains and elevated serum interleukin 6. Clin. Chim. Acta. 197, 221-228, 1991.
187. Campbell, I. L., Hobbs, M. V., and Dockter, J. Oldstone-MB; Allison-JIslet inflammation and hyperplasia induced by the pancreatic islet-specific overexpression of interleukin-6 in transgenic mice. Am. J. Pathol. 145, 157-66, 1994.
188. Campbell, I. L., Kay, T. W., Oxbrow, L., and Harrison, L. C. Essential role for interferon-g and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/wehi mice. J. Clin. Invest. 87, 739-742, 1991.
189. Finck, B. A. K., Chan, B , and Wofsy, D. Interleukin 6 promotes murine lupus in NZB/NZW F1 mice. J. Clin. Invest. 94, 585-91, 1994.
190. Potter, M. Genetics of susceptibility to plasmacytoma development in BALB/c mice. Cancer Surveys 3, 247-264, 1984.
191. Jacob, C. O. and McDevitt, H. O. Genetic predisposition to autoimmune diseases, the contribution of the major histocompatibility complex. In: Molecular Autoimmunity 1991. edited by Talal. N. London: Academic Press, pp. 7-29.
192. Jacob, C. O. and McDevitt, H. O. Interferon gamma and tumor necrosis factor in autoimmune disease models: implications for immunoregulation and genetic susceptibility. In: Molecular Autoimmunity 1991, edited by Talal, N. London: Academic Press, pp. 107-126.
193. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., and Nagata, S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 256, 314-317, 1992.
194. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkink, N. A., Copeland, N. G., Suda, T., and Nagata, S. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand, Cell 76, 969-976, 1994.
195. Hirano, T. Interleukin-6 and its relation to inflammation and disease. Clinical Immunol. and Immunapathol. 62, S60-S65, 1992.
196. Hirano, T. Interleukin 6 and autoimmunity and plasma cell neoplasias. Res. Immunol. 143, 759-763, 1992.
197. Hirano, T. Interleukin 6 transgenic mouse: A model of chronic inflammatory proliferative disease. In: Overexpression and knockout of cytokines in transgenic mice. 1994, edited by Jacob, C. O., London: Academic Press, pp. 73-84.
198. Kaisho, T., Oritani, K., Ishikawa, J., Tanabe, M., Muraoka, O., Ochi, T., and Hirano, T. Human bone marrow stromal cell lines from myeloma and rheumatoid arthritis which can support murine preB cell growth. J. Immunol. 149, 4088-4095, 1992.
199. Kaisho, T., Ishikawa, J., Oritani, K., Inazawa, J., Tomizawa, H., Muraoka, O., Ochi, T., and Hirano, T. BST-1, a surface molecule of bone marrow stromal cell lines that facilitates pre-B cell growth. Proc. Natl. Acad. Sci. USA 91, 5325-5329, 1994.
200. Garry, R. F., Fermin, C. D., Hart, D. J., Alexander, S. S., Donehower, L. A., and Lou-Zhang, H. Detection of a human intracisternal A-type retroviral particle antigenically related to HIV. Science 250, 1127-1129, 1990.
201. Trabandt, A., Gay, R. E., Stransky, G., Aicher, W. K., and Gay, S. Cellular and molecular basis of rheumatoid joint destruction. In: Molecular Autoimmunity 1991, edited by Talal, K., London: Academic Press, pp. 233-245.
202. Kitajima, I., Yamamoto, K., Sato, K., Nakajima, Y., Nakajima, T., Maruyama, I., Osame, M., and Nishioka, K. Detection of human T cell lymphotropic virus type I proviral DNA and its gene expression in synovial cells in chronic inflammatory arthropathy. J. Clinical Investigation 88, 1315-1322, 1991.
203. Iwakura, Y., Tosu, J., Yoshida, E., Takiguchi, M., Sato, K., Kitajima, I., Nishioka, K., Yamamoto, K., Takeda, T., Hatanada, M., Yamamoto, H., and Sekiguchi, T. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science 253, 1026-1028, 1991.
204. x encoded by human T-cell leukemia virus type 1. EMBO J. 5, 2883-2888, 1986.
205. Maruyama, M., Shibuya, H., Harada, H., Hatakeyama, M., Seiki, M., Fujita, T., Inoue, J., Yoshida, M., and Taniguchi, T. Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-I encoded p40x and T3/Ti complex triggering. Cell 48, 343-350, 1987.
206. Cross, S. L., Feinberg, M. B., Wolf, J. B., Holbrook, N. J., Wong-Staal, F., and Leonard, W. J. Regulation of the human interleukin-2 receptor chain promoter: activation of a nonfunctional promoter by transactivator gene of HTLV-I. Cell 49, 47-56, 1987.
207. Arai, N., Nomura, D., Villaret, D., Malefijt, R. D., Seiki, M., Yoshida, M., Minoshima, S., Fukayama, R., Mackawa, M., Kudoh, J., Shimizu, N., Yokota, K., Abe, E., Yokota, T., Takebe, Y., and Arai, K. Complete nucleotide sequence of the chromosomal gene for human IL-4 and its expression. J. Immunol. 142, 274-282, 1989.
208. Nimer, S. D., Gasson, J. C., Hu, K., Smalberg, I., Williams, J. L., Chen, I. S., and Rosenblatt, J. D. Activation of the GM-CSF promoter by HTLV-I and -II tax proteins. Oncogene 4, 671-676, 1989.
209. Kim, S. J., Kehrl, J. H., Burton, J., Tendler, C. L., Jeang, K. T., Danielpour, D., Thevenin, C., Kim, K. Y., Sporn, M. B., and Robert, A. B. Transactivation of the transforming growth factorb1 (TGF-b1) gene by human T lymphotropic virus type 1 tax: A potential mechanism for the increased production of TGF-b1 in adult T cell leukemia. J. Exp. Med. 172, 121-129, 1990.
210. Martinez-Maza, O. IL-6 and AIDS. Res. Immunol. 143, 764-769, 1992.
211. Muraoka, O., Kaisho, T., Tanabe, M., and Hirano, T. Transcriptional activation of the interleukin 6 gene by HTLV-1 p40tax through an NF-kB-like binding site. Immunol. Letter 37, 159-165, 1993.
212. Armstrong, M. Y. K., Ebenstein, P., Konigsberg, W. H., and Richards, F. F. Endogenous RNA tumor viruses are activated during chemical induction of murine plasmacytomas. Proc. Natl. Acad. Sci. USA 75, 4549-4552, 1978.
213. Feghali, C. A., Bost, K L., Boulware, D. W., and Levy, L. S. Control of IL-6 expression and response in fibroblasts from patients with systemic sclerosis. Autoimmunity 17(4), 309-18, 1994.